Polymorphism and plasma levels of apolipoprotein E and the risk of aneurysmal subarachnoid hemorrhage in a Chinese population: a case-control study

[1]  Shuyi Han,et al.  Serum apolipoprotein E concentration and polymorphism influence serum lipid levels in Chinese Shandong Han population , 2016, Medicine.

[2]  D. Bhat,et al.  Polymorphisms of apolipoprotein E and aneurysmal subarachnoid haemorrhage: A meta-analysis , 2016, Meta gene.

[3]  R. Mahley.  Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders , 2016, Journal of molecular medicine.

[4]  K. Blennow,et al.  Apolipoprotein E polymorphism in aneurysmal subarachnoid haemorrhage in West Sweden , 2016, Acta neurologica Scandinavica.

[5]  F. Gao,et al.  Apolipoprotein E gene polymorphism and the risk of subarachnoid hemorrhage: a meta-analysis of case–control studies , 2016, Acta Neurochirurgica.

[6]  J. Kaprio,et al.  Cholesterol as a Risk Factor for Subarachnoid Hemorrhage: A Systematic Review , 2016, PloS one.

[7]  Maode Wang,et al.  Apolipoprotein E polymorphism and the risk of intracranial aneurysms in a Chinese population , 2016, BMC Neurology.

[8]  Zhiping Hu,et al.  ApoE Polymorphisms and the Risk of Different Subtypes of Stroke in the Chinese Population: A Comprehensive Meta-Analysis , 2016, Cerebrovascular Diseases.

[9]  R. Du,et al.  Role of Genetic Polymorphisms in Predicting Delayed Cerebral Ischemia and Radiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis. , 2015, World neurosurgery.

[10]  S. Abdul-Razak,et al.  Low Serum High Density Lipoprotein Cholesterol Concentration is an Independent Predictor for Enhanced Inflammation and Endothelial Activation , 2015, PloS one.

[11]  R. Mahley,et al.  Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases , 2014, Neurobiology of Disease.

[12]  J. Bartek,et al.  Modifiable Risk Factors for Aneurysmal Subarachnoid Hemorrhage , 2013, Stroke.

[13]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[14]  R. Mahley,et al.  Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology , 2012, Neuron.

[15]  L. Gu,et al.  Apolipoprotein E polymorphism in normal Han Chinese population: frequency and effect on lipid parameters , 2009, Molecular Biology Reports.

[16]  Guojun Bu,et al.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy , 2009, Nature Reviews Neuroscience.

[17]  Pankaj Sharma,et al.  The Genetics of Primary Haemorrhagic Stroke, Subarachnoid Haemorrhage and Ruptured Intracranial Aneurysms in Adults , 2008, PloS one.

[18]  J. Broderick,et al.  Subarachnoid hemorrhage: tests of association with apolipoprotein E and elastin genes , 2007, BMC Medical Genetics.

[19]  M. Pérez-García,et al.  Description of Quality of Life and Its Predictors in Patients with Aneurysmal Subarachnoid Hemorrhage , 2007, Cerebrovascular Diseases.

[20]  A. Algra,et al.  Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[21]  K. Nozaki,et al.  Association Analysis of Common Variants of ELN, NOS2A, APOE and ACE2 to Intracranial Aneurysm , 2006, Stroke.

[22]  Craig S. Anderson,et al.  Risk Factors for Subarachnoid Hemorrhage: An Updated Systematic Review of Epidemiological Studies , 2005, Stroke.

[23]  G. Murray,et al.  The association between APOE « 4 , age and outcome after head injury : a prospective cohort study , 2005 .

[24]  H. Nam,et al.  Copyright � The Korean Academy of Medical Sciences The Effect of Apolipoprotein E Polymorphism on Lipid Levels in Korean Adults , 2004 .

[25]  G. Stein,et al.  Serum lipids as protective factors for subarachnoid hemorrhage , 2005, Journal of Clinical Neuroscience.

[26]  David F Kallmes,et al.  Subarachnoid hemorrhage: neurointensive care and aneurysm repair. , 2005, Mayo Clinic proceedings.

[27]  Jie Tang,et al.  Apolipoprotein e ϵ4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage , 2003 .

[28]  G. Siest,et al.  Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. , 2000, Atherosclerosis.

[29]  G. Siest,et al.  Associations of Apolipoprotein E Concentration and Polymorphism with Lipids and Apolipoprotein Levels in Chinese from Beijing and Shanghai , 2000, Clinical chemistry and laboratory medicine.

[30]  E. L. Teng,et al.  ApoE genotype in relation to AD and cholesterol , 1999, Neurology.

[31]  Sean Parkin,et al.  Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia , 1996, Nature Structural Biology.

[32]  J. Broderick,et al.  Initial and Recurrent Bleeding Are the Major Causes of Death Following Subarachnoid Hemorrhage , 1994, Stroke.

[33]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[34]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Boerwinkle,et al.  The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. , 1991, American journal of human genetics.

[36]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[37]  C. Symonds,et al.  Spontaneous Sub-Arachnoid Hæmorrhage , 1924, Proceedings of the Royal Society of Medicine.

[38]  R. Mahley.  Apolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases. , 2017, Clinical chemistry.

[39]  M. Muiesan,et al.  Nutraceuticals and dyslipidaemia: Beyond the common therapeutics , 2014 .

[40]  A. Girija,et al.  Low cholesterol as a risk factor for primary intracerebral hemorrhage: A case–control study , 2012, Annals of Indian Academy of Neurology.

[41]  S. Mohiuddin,et al.  Low high-density lipoprotein cholesterol is associated with impaired endothelial function in Asian Indians. , 2005, Ethnicity & disease.

[42]  G. Murray,et al.  The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. , 2005, Brain : a journal of neurology.

[43]  Jie Tang,et al.  Apolipoprotein E epsilon4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage. , 2003, Surgical neurology.

[44]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.